The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Early retirement planning is essential for achieving financial freedom. Discover the benefits of starting your planning now.
25,214 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Investors chasing SpaceX-style wins without a private bet must weigh public players carefully. This guide compares AS...
Honda is shifting strategy, moving toward hybrids while still pursuing a carbon-neutral future. This pivot changes ho...
Archer Aviation stock popped last month as investors weighed milestones in eVTOL development, defense partnerships, a...
Qualcomm and Marvell shares slide after ByteDance signals a move into custom AI silicon, sparking a broader reassessm...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...
SpaceX's IPO headlines would be enormous and tempting. This article shares the one clear message I’d tell every inves...
Markets wobble, but three names stand out for patient investors. Learn why Microsoft, NVIDIA, and The Trade Desk are ...
Unlock actionable takeaways from the 2026 earnings call transcript for IFS. This guide translates the quarter’s numbe...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Upstart has been navigating a challenging stretch as the stock declines. This article breaks down whether the drop cr...